Evidence map›Paper›PMID 40315238›Full record

ArticlePloS one2025

The relationship between dementia staging scales, cognitive-behavioral scales and functionality in patients with cognitive impairment.

Fatma Ozge Kayhan Koçak, Emre Kumral

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Fatma Ozge Kayhan KoçakDivision of Geriatrics, Department of Internal Medicine, Health Sciences University Tepecik Training and Research Hospital, İzmir, Turkiye.ORCID https://orcid.org/0000-0002-6447-2352
Emre KumralDepartment of Neurology, Faculty of Medicine, Ege University, İzmir, Turkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe aim of this study is to retrospectively evaluate the relationship between dementia stage, cognitive and behavioral scales, and functional status in patients with cognitive impairment.

methodsThe medical records of patients over 50 years of age, who were followed up for cognitive impairment at the neurology outpatient clinic were retrospectively scanned between January 1990 and November 2022. The Clinical Dementia Rating (CDR), Global Deterioration Scale (GDS) and Functional Assessment Staging Test (FAST), The Mini Mental State Examination (MMSE) and the Alzheimer's Disease Assessment Scale-Cognitive Subscore (ADAS-Cog) were recorded. The neuropsychiatric symptoms were evaluated by the Neuropsychiatric Inventory (NPI) and The Behavioral Pathology in Alzheimer's Disease Rating Scale (BEHAVE-AD). Patients' Instrumental Assessment of Daily Living (IADL) scores were recorded to assess functional capacity.

resultsThis study analyzed 871 patients with cognitive impairment, 69.8% of whom were having functional impairment. Alzheimer's disease was the most common type of dementia (64.6%), with memory problems as the key symptom (65.6%). Neuropsychiatric symptoms such as hallucinations, delusion, and eating disturbances were significantly associated with disability (p < 0.001), while depression and anxiety were not. CDR scale was the strongest predictor of disability (OR: 4.9, AUC = 0.740), outperforming other dementia staging scales. Cognitive and behavioral scales like MMSE and NPI showed stronger correlations with functional impairment than with the dementia staging scales (-0.132 < rs < 0.472, p < 0.001 and -0.284 < rs < -0.357, p < 0.001, respectively).

conclusionOur study demonstrated that both cognitive status and behavioral symptoms are critical in determining the level of functional impairment in cognitive impairments, but their contributions differ in magnitude and focus. As well as cognitive decline, neuropsychiatric symptoms may also need targeted management to reduce their impact on functionality. We need a practical tool that can be used in all stages of dementia, that does not overlook the impact of neuropsychological symptoms, and that can assess ADL according to the needs of patients and carers.

Indexed as

CognitionCognitive DysfunctionDementiaActivities of Daily LivingAgedAged, 80 and overAlzheimer DiseaseFemaleHumansMaleMental Status and Dementia TestsMiddle AgedNeuropsychological TestsRetrospective StudiesSeverity of Illness Index

Identifiers

PMID40315238
PMCPMC12047750

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.